ICAM1 and lung carcinoma: In addition, we performed γδ TCR and NKG2D blocking assays to determine whether DAC-mediated ICAM-1 upregulation may override the conventional tumor recognition mechanisms through γδ TCR or NKG2D at the interface between γδ T cells and DAC-pretreated lung cancer cells.